An 85-year-old man presented with an 8-month history of slowly increasing diffuse yellow skin lesions on the torso and upper arms. He had been unaware of the discoloration until his internist noted it and referred him to dermatology. The patient had been followed by a hematologist for paraproteinemia that had not been treated. 
is characterized by the presence of symmetric yellowishorange plaques that favor the neck, upper trunk, flexural folds and periorbital region [1, 2] . Histologically, foam cells (macrophages that have engulfed lipid droplets) and variable numbers of Touton giant cells, lymphocytes, and foamy histiocytes can be seen [3] .
While not all cutaneous xanthomas are associated with systemic diseases, DNPX has been associated with systemic 
Discussion
Diffuse normolipemic plane xanthoma (DNPX) was first described by Altman and Winkelmann in 1962 [1] . It is an uncommon subtype of non-Langerhans histiocytosis [15] .
DNPX is characterized by xanthelasma palpebrarum; diffuse plane xanthoma of the head, neck, trunk, and extremities; and normal plasma lipid levels [2, 4] . Xanthelasma typically appears first, followed by involvement of the lateral parts of the neck and upper trunk [1] . Clinically, the dermatosis The pathogenesis of DNPX has not been fully elucidated, however, in gammopathy-associated DNPX, monoclonal IgG is thought to bind to circulating LDL, rendering the antibody-LDL complex more susceptible to phagocytosis by macrophages [13] . DNPX can precede such disorders by several years; therefore close follow-up with periodic laboratory tests for myeloproliferative disorders should be performed [4] .
There are currently several treatment options available.
In patients with limited involvement, the individual lesions can be excised. Other options include chemabrasion, dermabrasion, and ablative laser therapy. The erbium:YAG laser has been used successfully to treat facial xanthomas in one patient [14] .
In this patient, currently there are no associated systemic symptoms. His hematologist was informed of the diagnosis. The patient will be evaluated for potential underlying malignancies. Moreover, this case shows that dermatological lesions can be the first manifestation of important hematological diseases and so physicians should be familiarized with this rare entity.
